Latest Market Entry News

OncoSil Medical reports a remarkable 917% increase in quarterly cash receipts alongside promising clinical trial results and key European market entries, signaling robust momentum in its pancreatic cancer treatment rollout.

CurveBeam AI reports a 33% increase in Q1 FY26 purchase orders, secures A$6.5 million in new funding, and finalizes a strategic joint venture for China distribution and manufacturing rights.

De.mem Limited has reported its second highest quarterly cash receipts alongside record revenues and EBITDA for Q3 2025, boosted by a key acquisition expanding its footprint in the gold mining sector.

SportsHero has launched its iGV Game Pass subscription in the Philippines through a strategic partnership with PLDT Home, tapping into a booming PC gaming market.

CurveBeam AI has inked a decade-long exclusive partnership with a major Chinese medical device joint venture, unlocking rapid market entry and a $10 million capital boost to expand its weight bearing CT and AI solutions across Greater China.

Tissue Repair Limited reports steady progress in its Phase 3 clinical trials for chronic wound treatment and advances regulatory filings for its TR Pro+® product, while gearing up for a major commercial rollout in early 2026.

Green Critical Minerals advances its Very High Density graphite technology with strong thermal performance validation, production scale-up, and strategic moves into global markets including a planned US listing.

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.

VRX Silica Limited has secured critical environmental and mining approvals for its Arrowsmith North silica sand project, alongside binding offtake contracts with major Asian customers, setting the stage for production by late 2026.

Bass Oil reported steady quarterly oil production with a 20% increase in Indonesian output following a production enhancement program. The company is poised to enter the East Coast Gas Market pending regulatory approval for the Vanessa gas field acquisition.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.